MOTS-c benefits explained: what animal research suggests, the July 2026 FDA panel vote, and MOTS-c prices from Real Peptides and Peptide God compared.
Independently ranked by quality, purity and value.
MOTS-c is a mitochondrial-derived peptide studied for metabolic and exercise-capacity research.
MOTS-c is a mitochondrial-derived peptide studied for exercise capacity, insulin sensitivity and metabolic aging.
5-Amino-1MQ is studied for its role in NNMT inhibition and metabolic research. Lab tested per lot.
NAD+ research peptide in a multi-dose vial. Independent lab tested with COA published per lot. Ships from US stock.
Order online; most orders arrive in a few days in discreet packaging.
Every guide is reviewed by at least one member of this panel before publication.
Science journalist who fact-checks every claim against primary literature and ensures our guides stay accurate after each update.
Biostatistician who reviews trial design, endpoint selection and efficacy data for every peptide covered in our guides.
PhD in molecular pharmacology. Evaluates the published animal and clinical data behind every peptide we cover.
Monitors FDA enforcement actions, WADA updates and international peptide import rules. Updates our legal guides monthly.
Every pick has a batch-matched certificate of analysis we can read.
We check that real potency matches what the label promises.
Simple, transparent formulas — no mystery fillers or additives.
Scored on real cost per serving, not just sticker price.
On 23 July 2026, FDA's Pharmacy Compounding Advisory Committee voted 8-6, with one abstention, to recommend MOTS-c for the list of bulk substances that compounding pharmacies may use. That vote is the newest hard fact in a field that otherwise runs on animal studies, and it is a good place to start any honest look at MOTS-c benefits.
This site follows MOTS-c from the research-supply side: what the lab and animal work suggests, where it stops, what the regulators have and have not decided, and what the two vendors we track charge. MOTS-c is not an FDA-approved drug. Every product discussed here is sold labelled for research use only, not for human consumption.
Most of the studies investigating the role that MOTS-c plays have dwelled on metabolism and exercise. In addition, the majority of studies were conducted on animals as opposed to humans. Because research has shown that MOTS-c is a peptide derived from the mitochondria, it is encoded by genes found in mitochondria instead of in the nucleus. Scientists have opted to study MOTS-c since this origin explains its function as a messenger between cell energy processes and other physiological systems within the body.
Researchers have explored the connection between MOTS-c and metabolic markers and performance in animals. This is something that vendors pay attention to as well. For instance, Peptide God has placed its MOTS-c product within the category “Metabolism & endurance research” stating that its offering involves a research approach that is exercise mimetic. This approach does not refer to actual research findings in humans.
For the background on the peptide itself, our page on what MOTS-c is explains the mitochondrial DNA story without the sales language.
The proof stops with animals as no controlled human studies have demonstrated that MOTS-c has an impact on metabolism, weight, or exercise results in humans. The two vendors themselves point this out in their ads. Peptide God mentions "Lack of human data" (negative) while Real Peptides lists the product as "Research use only" (negative).
The importance of this gap outweighs any individual animal study outcome. Experiments performed on rodents depend on controlled dietary conditions, exercise, and dosage administered based on experimental parameters. None of these factors can be directly compared with humans. Therefore, mice results provide a valid ground for human studies, but cannot replace them.
Safety is the other open question. Without human trials, nobody can list a reliable side-effect profile, which is why our MOTS-c side effects page spends more time on what is unknown than on what is known.
The July 2026 vote was a recommendation, not an approval, and it did not make MOTS-c legal to compound. The committee voted on whether to add MOTS-c to the 503A bulks list, the list of substances compounding pharmacies may use. MOTS-c passed 8-6 with one abstention, the same count recorded that day for BPC-157, TB-500 and KPV.
The vote is non-binding. FDA still has to make its own decision, then publish a proposed rule, take public comment and issue a final rule. As of the July meeting, MOTS-c had not been added and compounding it was not yet permitted. We cover the full timeline on the MOTS-c and FDA page.
Two research vendors on this site sell MOTS-c, and their listings differ on price, stated size and shipping terms.
| Vendor | Product | Price | Stated size | Free US shipping | Returns |
|---|---|---|---|---|---|
| Real Peptides | MOTS-c Peptide | $43.20 | 10mg, lyophilized powder | Orders over $250 | Not stated |
| Peptide God | MOTS-c | $49.95 | Not stated, lyophilized powder | Orders over $100 | 30-day free returns |
The cost of the vial from Real Peptides is $4.32 per mg. The Peptide God listing does not provide the size of the vials so it is impossible to calculate the price per mg. However, it is important to confirm the size in either the product label or by contacting the seller. One thing which buyers usually overlook is that two vials from Peptide God add to $99.90, just a dime short of free shipping.
Real Peptides says it publishes a third-party COA, and Peptide God describes its product as lab-tested at 99% purity or higher. The MOTS-c vendor page compares those claims in more detail.
When examining MOTS-c, most buyers tend to consider two other compounds available in the same domain of metabolic and ageing processes, 5-Amino-1MQ and NAD+.
A MOTS-c vial, a 5-Amino-1MQ pack and an NAD+ vial from Real Peptides add up to $136.80, still well under the $250 free-shipping threshold. Neither 5-Amino-1MQ nor NAD+ was part of the July 2026 panel vote.
Every MOTS-c claim related to benefits is evaluated by us as a claim regarding research direction until any trials involving humans prove otherwise. In practice, this requires a brief checklist of items:
None of this is medical advice. If you are thinking about any metabolic compound for your own health, talk to your doctor first.